Search results

1 – 10 of 12
Expert briefing
Publication date: 10 November 2017

Amid continuing concerns about public spending and debt levels, Laos’s finance ministry in mid-October enacted its largest foreign bond issue yet. An October report by the…

Expert briefing
Publication date: 27 April 2020

Calls for China to be more transparent over COVID-19's origins and spread.

Details

DOI: 10.1108/OXAN-DB252213

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 25 August 2020

An already stretched and spartan economy has been hammered this year by anti-pandemic curbs which have hit trade, and now by severe flooding. Another typhoon is expected in coming…

Details

DOI: 10.1108/OXAN-DB254804

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 18 May 2015

The outlook for Cambodia's 'culture of dialogue'.

Expert briefing
Publication date: 15 April 2020

COVID-19 and the surveillance state.

Details

DOI: 10.1108/OXAN-DB251958

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 4 February 2022

SPACs -- also known as ‘blank-cheque’ companies -- raise money through initial public offerings (IPOs) and then look to merge with or acquire private firms, thereby giving the…

Expert briefing
Publication date: 15 January 2021

The Mekong flows through China and the five mainland South-east Asian states -- Myanmar, Thailand, Cambodia, Laos and Vietnam. Earlier this month, China belatedly informed the…

Expert briefing
Publication date: 7 December 2020

South Korea's conglomerates are symbols of national pride and jobs with them are highly sought after, but their faults are roundly criticised. Samsung, the largest, is widely…

Details

DOI: 10.1108/OXAN-DB258019

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 30 January 2020

The government's response to the novel coronavirus in Wuhan.

Details

DOI: 10.1108/OXAN-DB250353

ISSN: 2633-304X

Keywords

Geographic
Topical
Expert briefing
Publication date: 12 January 2021

Earlier this month, the Drugs Controller General of India (DCGI) approved the Oxford/AstraZeneca vaccine, marketed in India as ‘Covishield’, and a locally developed jab. The…

Access

Year

Content type

Expert briefing (12)
1 – 10 of 12